[Retracted] MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
1/5 보강
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that most of the flow cytometric data shown in Fig.
APA
Li K, Yuan C (2026). [Retracted] MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.. International journal of molecular medicine, 57(1). https://doi.org/10.3892/ijmm.2025.5695
MLA
Li K, et al.. "[Retracted] MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.." International journal of molecular medicine, vol. 57, no. 1, 2026.
PMID
41268601 ↗
Abstract 한글 요약
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that most of the flow cytometric data shown in Fig. 5A on p. 1020 were strikingly similar to data which had been already been submitted for publication to several other journals that were written by different authors at different research institutes. Owing to the fact that the contentious data in the above article were found to be strikingly similar to data that had already been submitted, or accepted, for publication elsewhere, the Editor of has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Molecular Medicine 46: 1013‑1028, 2020; DOI: 10.3892/ijmm.2020.4649].
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- An X-ray and γ-ray combination strategy to exploit steep dose gradients for improved prostate cancer radiotherapy: A dosimetric comparison of Taichi Pro and Halcyon.
- Traditional Cox regression outperforms large language models in predicting long-term progression of intermediate to advanced hepatocellular carcinoma.
- [Expression of Concern] Leptin promotes breast cancer cell migration and invasion via IL‑18 expression and secretion.
- Regorafenib and Nifuroxazide exert enhanced suppression of hepatocellular carcinoma by inhibiting STAT3 and immune remodeling.
- Revisiting Gender Differences in Gastric Cancer Prevention With Helicobacter pylori Eradication Therapy.